These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

70 related articles for article (PubMed ID: 3248945)

  • 41. Microbiology and pharmacology of aztreonam.
    Duma RJ
    Urology; 1988 Jun; 31(6 Suppl):9-13. PubMed ID: 3287750
    [TBL] [Abstract][Full Text] [Related]  

  • 42. High level resistance in gram negative bacilli.
    Gupta N; Aparna ; Saini S; Arora DR
    Indian J Pathol Microbiol; 2004 Oct; 47(4):594-5. PubMed ID: 16295409
    [No Abstract]   [Full Text] [Related]  

  • 43. [Antibacterial drug resistance of gram-negative agents causing urinary infections in female outpatients in Russia: results of multicenter study].
    Strachunskiĭ LS; Sekhin SV; Abramova ER; Reshed'ko GK; Petrochenkova NA; Eĭdel'shteĭn IA; Suvorov MM; Krechikova OI; Il'ina VN; Petrova TA; Gugutsidze EN; Furletova NM
    Ter Arkh; 2000; 72(6):30-5. PubMed ID: 10900645
    [TBL] [Abstract][Full Text] [Related]  

  • 44. In vitro activity of CI-934 and other antimicrobial agents against gram-positive and gram-negative bacteria.
    Smith RP; Baltch AL; Hammer MC; Conroy JV
    Clin Ther; 1986; 9(1):106-18. PubMed ID: 3815456
    [TBL] [Abstract][Full Text] [Related]  

  • 45. In vitro activity of isepamicin and other aminoglycosides against clinical isolates of Gram-negative bacteria causing nosocomial bloodstream infections.
    Tsai TY; Chang SC; Hsueh PR; Feng NH; Wang JT
    J Microbiol Immunol Infect; 2007 Dec; 40(6):481-6. PubMed ID: 18087627
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Comparative in vitro evaluation of BMY-28142, a new broad-spectrum cephalosporin, versus other beta-lactams against multiresistant gram-negative isolates.
    Giamarellou H; Sahin A; Chryssouli Z
    Drugs Exp Clin Res; 1987; 13(3):149-53. PubMed ID: 3622243
    [TBL] [Abstract][Full Text] [Related]  

  • 47. In vitro activities of 'new' and 'conventional' antibiotics against multi-drug resistant Gram negative bacteria from patients in the intensive care unit.
    Ratnam I; Franklin C; Spelman DW
    Pathology; 2007 Dec; 39(6):586-8. PubMed ID: 18027263
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Serious interpretive error among three commercial systems for susceptibility testing of aztreonam. Aztreonam Study Group.
    Marshall SA
    Diagn Microbiol Infect Dis; 1995 Jul; 22(3):249-51. PubMed ID: 8565412
    [No Abstract]   [Full Text] [Related]  

  • 49. Comparative in vitro activity of imipenem and nine other antimicrobials against recently isolated pathogens.
    Bonadio M; Maccanti O; Cosci S; Giordani R
    J Chemother; 1989 Jul; 1(4 Suppl):58-60. PubMed ID: 16312303
    [No Abstract]   [Full Text] [Related]  

  • 50. [Antibiotic sensitivity of gram negative bacilli isolated from urinary tract infections at NUHC of Cotonou (Benin) from March to December 1992].
    Anagonou SY; Eslahpazire J; Makoutodé M; Josse R; Massougbodji A; Sadeler BC
    Bull Soc Pathol Exot; 1994; 87(4):223-5. PubMed ID: 7866038
    [TBL] [Abstract][Full Text] [Related]  

  • 51. In vitro activity of ciprofloxacin in comparison with aztreonam, imipenem, and ceftazidime against multiply resistant strains.
    Nemes G; Stolle D; Nemes P
    Chemioterapia; 1987 Jun; 6(2 Suppl):133-5. PubMed ID: 3334552
    [No Abstract]   [Full Text] [Related]  

  • 52. [Non-fermenting Gram-negative bacteria of human origin. II. In vitro sensitivity of 185 strains to 17 antibiotics and chemotherapeutic agents in clinical use].
    Paredes L; Thompson L; del Canto E; Paredes L
    Rev Latinoam Microbiol; 1986; 28(2):109-16. PubMed ID: 3797861
    [No Abstract]   [Full Text] [Related]  

  • 53. [Is aztreonam could become "a challenger" for treatment of Gram negative infections? May be an answer from microbiological data: in vitro study including 36,485 strains of enterobacteria and Pseudomonas].
    Honderlick P; Gravisse J; Dardelle D; Cahen P
    Pathol Biol (Paris); 2007 Dec; 55(10):475-7. PubMed ID: 17904768
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Interpretive errors using an automated system for the susceptibility testing of imipenem and aztreonam.
    Biedenbach DJ; Jones RN
    Diagn Microbiol Infect Dis; 1995 Jan; 21(1):57-60. PubMed ID: 7789099
    [No Abstract]   [Full Text] [Related]  

  • 55. [Aminoglycoside activity in relation to gram-negative microflora isolated from heart surgery patients].
    Ostrovskaia EA; Khaimova MD
    Antibiotiki; 1983 Sep; 28(9):693-8. PubMed ID: 6638983
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Belgian multicenter study on the in vitro activity of aztreonam against gram-negative bacilli.
    Verbist L; Van der Auwera P
    Acta Clin Belg; 1988; 43(1):19-26. PubMed ID: 3284263
    [No Abstract]   [Full Text] [Related]  

  • 57. In-vitro activity of aztreonam in combination with four other antibiotics against gram-negative bacilli and Staphylococcus aureus.
    Ampel NM; Moon-McDermott L; Keating M; Zinner SH
    J Antimicrob Chemother; 1984 Apr; 13(4):398-9. PubMed ID: 6539326
    [No Abstract]   [Full Text] [Related]  

  • 58. Induction of beta-lactamases in gram-negative bacilli.
    Wise R; Ashby JP; Piddock LJ
    J Antimicrob Chemother; 1987 Nov; 20(5):767-8. PubMed ID: 3501423
    [No Abstract]   [Full Text] [Related]  

  • 59. In vitro antibacterial activity of aztreonam against gram-negative bacilli isolated in 1985.
    Miyake Y; Yokoyama T; Nakano H; Kuwabara M; Yamakido M; Suginaka H
    Hiroshima J Med Sci; 1988 Sep; 37(3):115-7. PubMed ID: 3248945
    [No Abstract]   [Full Text] [Related]  

  • 60. Comparative in-vitro antibacterial activity of aztreonam against clinical isolates of gram-negative bacteria.
    Shibl AM; Ishag AH; Durgham SM
    J Chemother; 1989 Jul; 1(4 Suppl):359-61. PubMed ID: 16312439
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.